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Summary We describe a rare case of tricuspid valve endocarditis caused by Pasteurella
multocida in an elderly woman with no previous history of valvular heart disease. Risk factors
included contact with animals and old age. The patient was treated successfully with five days of
intravenous ampicillin followed by four weeks of oral ciprofloxacin.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Pasteurella multocida, a Gram-negative coccobacillus, is a
common inhabitant of the oral cavity of dogs and cats.1 It is
rarely present in the respiratory tract of healthy humans.2
Systemic infections are rare and endocarditis has been occa-
sionally described.3 A total of 32 cases of endocarditis asso-
ciated with Pasteurella species have been reported so far,
from different parts of the world.3,4 To our knowledge, this is
the first report of P. multocida tricuspid valve endocarditis.
Case report
An 88-year-old female was admitted to the American Uni-
versity of Beirut Medical Center with high-grade fever, chills* Corresponding author. Division of Infectious Diseases, American
University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh
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doi:10.1016/j.ijid.2008.11.004and vomiting during the preceding 24 hours. The patient was
known to have hypertension, but was not known to have
valvular heart disease. Her vital signs upon admission were as
follows: blood pressure 150/89 mmHg, temperature 38.8 8C,
pulse 110 beats/min. Physical examination was only remark-
able for a grade yy/Vy systolic murmur on the left lateral
sternal border, and a red patch overlying the left pretibial
area with a central crusted lesion and a subcutaneous puru-
lent collection. There was mild edema of the leg, but no
enlarged inguinal lymph nodes. The patient reported being
bitten by her own cat two weeks before presentation. Her
white blood cell count was 10,500 cells/mm3, with 90%
neutrophils. A chest roentgenogram did not reveal any
abnormalities. Four blood culture bottles drawn during the
first 12 hours of hospitalization, in addition to culture of pus
aspirated from the pretibial collection, all yielded colonies of
P. multocida that were susceptible to penicillin G (MIC
0.25 mg/ml) and ciprofloxacin (MIC 0.012 mg/ml). Transthor-
acic echocardiography showed tricuspid valve vegetation
measuring 0.7  0.7 cm with mild tricuspid regurgitation.Published by Elsevier Ltd. All rights reserved.
e268 M.R. Naba et al.The patient was initially started on intravenous ampicillin at
12 g/day and then was discharged after five days on cipro-
floxacin 750 mg orally twice daily for one week. Upon follow-
up, the patient was stable. Ciprofloxacin was decreased to
500 mg orally twice daily and was continued for three addi-
tional weeks. Blood cultures during treatment and one week
after the end of antibiotic therapy. In addition, repeat
echocardiographic examination showed that the tricuspid
vegetation had not changed in size, but evidence of new
calcification was revealed. The mild tricuspid regurgitation
was also unchanged. The patient remained well over the
subsequent six months.
Discussion
Human infection due to P. multocida has been described
following animal bites or scratches, mainly from dogs and
cats.5 In general, human pasteurellosis is a locoregional
infection.2 It is usually not life threatening, but it can cause
a variety of diseases, ranging from focal abscesses to bac-
teremia and endocarditis.1 Pet owners are considered to be
at high risk, even without a definite history of bites.1 Soft
tissue and wound infections are usually characterized by the
rapid development of an intense inflammatory response.
Pain and swelling are usually prominent, and purulent dis-
charge is noted in about half of patients.6,7 Most patients
develop symptoms within 24 hours of the initial injury.
However, in this case, the patient presented two weeks
after the cat bite.
Bacteremia associated with P. multocida most commonly
accompanies localized infection by this organism.6 Systemic
complications are rare, except in immunocompromised
patients.6 Liver cirrhosis and chronic pulmonary disease
are thought to be predisposing factors for Pasteurella bac-
teremia.1,3,5,8 Pasteurella endocarditis is rare.5 It is charac-
terized by large vegetations; this hinders antibiotic
penetration and explains the failure of medical treatment
in some cases.4
A review of the English literature revealed a total of 31
cases of Pasteurella left-sided endocarditis, 25 of which
involved native valves (13 mitral valve, 11 aortic and 1
unspecified).3,4 A total of 24 patients received medical treat-
ment only and 7 required adjunctive surgical treatment.3,4
No oral antibiotic therapy was documented in any of the
cases. A significant proportion of patients with Pasteurella
left-sided endocarditis had a fatal outcome (12 out of 31).3,4
Right-sided endocarditis due to P. multocida has been
reported only once, involving the pulmonic valve of an
intravenous drug user. It was treated successfully both medi-
cally and surgically.4 However, P. multocida endocarditis of
the tricuspid valve has not been previously reported. In the
present case, none of the risk factors traditionally associated
with right-sided endocarditis were present, including intra-
venous drug use, or the presence of intravenous catheters or
implantable cardiac devices.
The patient described in this report had definite native
tricuspid valve endocarditis according to the modified Duke
criteria. She responded to medical treatment alone (a short
course of intravenous ampicillin followed by oral ciproflox-
acin), without the need for surgical intervention. We believe
this to be the first documented case of P. multocida endo-carditis treated with oral antibiotics. Pasteurella species are
generally susceptible to a number of antibiotics. Penicillin is
considered the drug of choice, but fluoroquinolones, second-
and third-generation cephalosporins, and carbapenems also
possess good activity against Pasteurella.9—11 Fluoroquino-
lones are a particularly attractive option because of their
high oral bioavailability. Oral fluoroquinolones have been
studied in the treatment of infective endocarditis. In a
randomized trial of right-sided staphylococcal endocarditis,
oral therapy with ciprofloxacin and rifampin was as effective
as parenteral therapy with oxacillin/gentamicin or vanco-
mycin/gentamicin.12 More recently, Foo and Lye reported a
case of tricuspid valve endocarditis due to methicillin-sus-
ceptible Staphylococcus aureus that was successfully treated
with oral levofloxacin and rifampin.13
In conclusion, left-sided infective endocarditis due to
Pasteurella species is associated with a high mortality
(30%).14 Tricuspid valve endocarditis due to P. multocida
can be treated medically and might not require surgical
intervention.
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